Pluristem Therapeutics Inc (PSTI)

[El Mago]

Pluristem Receives $830,000 Grant from Israeli Government for Development of the PLX-I Stem Cell Product
NEW YORK—(BUSINESS WIRE)—Pluristem Life Systems, Inc. (OTCBB:PLRS - News; DAX:PJT), a bio-therapeutics Company dedicated to the commercialization of products for a variety of malignant, degenerative and auto-immune indications, announced today that its fully owned subsidiary Pluristem Ltd has received a competitive research and development grant of about $830,000 from Israel’s prestigious Chief Scientist Office (CSO).